跳至主要内容
临床试验/NCT06773013
NCT06773013已完成不适用

Safety and Effectiveness of Sonu Acoustic Resonance Therapy for the Treatment of Pediatric Patients With Moderate to Severe Nasal Congestion.

Third Wave Therapeutics2 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2025年1月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
31
试验地点
2
主要终点
Serious adverse events

研究概览

简要总结

To demonstrate the safety and effectiveness of Sonu for the treatment of pediatric patients with moderate to severe nasal congestion.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Pediatric subjects between the ages of 12 to 21 years
  • Present with symptoms of nasal congestion for 1 month or more prior to treatment
  • Have a 24 hour reflective nasal congestion subscore of the TNSS of 2 or more on a 0 to 3 scale at the time of screening

排除标准

  • Head, nasal or sinus surgery within 3 months
  • Sinus infection diagnosed within the last month, or rhinitis medicamentosa
  • Documented history of nasal polyposis or mass
  • Pregnancy

结局指标

主要结局

Serious adverse events

时间窗: 2 weeks

Safety

Reduction in nasal congestion subscore

时间窗: 2 weeks

Effectiveness

次要结局

  • Adverse events(2 weeks)
  • Total Nasal Symptom Score (TNSS)(2 weeks)

研究者

发起方
Third Wave Therapeutics
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验